| Literature DB >> 25815155 |
Guy Rouquet1, Dianna E Moore2, Malcolm Spain3, Daniel M Allwood1, Claudio Battilocchio1, David C Blakemore3, Paul V Fish3, Stephen Jenkinson4, Alan S Jessiman3, Steven V Ley1, Gordon McMurray3, R Ian Storer3.
Abstract
A series of pyrido[3,4-d]azepines that are potent and selective 5-HT2C receptor agonists is disclosed. Compound 7 (PF-04781340) is identified as a suitable lead owing to good 5-HT2C potency, selectivity over 5-HT2B agonism, and in vitro ADME properties commensurate with an orally available and CNS penetrant profile. The synthesis of a novel bicyclic tetrasubstituted pyridine core template is outlined, including rationale to account for the unexpected formation of aminopyridine 13 resulting from an ammonia cascade cyclization.Entities:
Keywords: 5-HT2C receptor agonist; CNS penetration; Tetrasubstituted pyridines; pyrido[3,4-d]azepine
Year: 2015 PMID: 25815155 PMCID: PMC4360148 DOI: 10.1021/ml500507v
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345